Benzenemethanol, α-[2-(1-naphthalenyloxy)ethyl]-, 1-methanesulfonate
Fluoxetine methasulfonate analog (racemic mixture) is a fully characterized chemical compound used as a reference standard of API Fluoxetine. The standard offered is compliant with regulatory guidelines. Fluoxetine methasulfonate analog (racemic mixture) is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 1445281-20-8
Related products
Fluoxetine Impurity C HCl (Fluoxetine USP Related Compound A HCl)
M.F.
M.W. 309.33 ; 36.46
CAT# AR-F01761
CAS# 79088-29-2
Atomoxetine Related Compound A (Fluoxetine EP Impurity A)
M.F.
M.W. 165.24
CAT# AR-F01759
CAS# 42142-52-9
Fluoxetine N-Glucuronide Sodium Salt (Mixture of Diastereomers)
M.F.
M.W. 484.45 22.99
CAT# AR-F01763
CAS# 96735-71-6 (free base)
Fluoxetine methasulfonate analog (racemic mixture)
M.F.
M.W. 356.44
CAT# AR-F09476
CAS# 1445281-20-8
